Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors

2 clinical trials · Condition

Record	Firm	Date
Safety And Efficacy Study Of Sunitinib Malate In Chinese Patients With Imatinib Resistant Or Intolerant Malignant Gastrointestinal Stromal Tumor (NCT00793871)	Pfizer	2008-11-01
Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors (NCT06948955)	Cogent Biosciences, Inc.

Every clearance here is in the API, with alerts when new ones post.